Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Tenet Healthcare (NYSE:THC) from a buy rating to a strong-buy rating in a research note published on Sunday.

Other research analysts also recently issued research reports about the stock. Robert W. Baird raised their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research report on Tuesday, July 28th. KeyCorp reduced their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Royal Bank Of Canada raised their price objective on Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a report on Monday, July 27th. Piper Sandler set a $308.00 target price on Tenet Healthcare in a report on Monday, July 27th. Finally, Truist Financial increased their price target on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $273.00.

Tenet Healthcare Stock Down 0.1%

Shares of Tenet Healthcare stock opened at $280.60 on Friday. The firm has a market cap of $22.59 billion, a PE ratio of 10.82, a P/E/G ratio of 1.07 and a beta of 1.23. The business’s 50 day simple moving average is $220.53 and its 200 day simple moving average is $206.93. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $280.89.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period last year, the business earned $4.02 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, analysts predict that Tenet Healthcare will post 20.97 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director Christopher S. Lynch sold 3,837 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total value of $934,079.28. Following the sale, the director owned 9,568 shares in the company, valued at $2,329,233.92. This represents a 28.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 41,375 shares of company stock worth $9,793,347 over the last ninety days. Company insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds have recently added to or reduced their stakes in the business. Triumph Capital Management bought a new position in shares of Tenet Healthcare in the third quarter valued at about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the 4th quarter valued at about $29,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the 2nd quarter valued at about $35,000. Finally, Trust Co. of Vermont acquired a new stake in Tenet Healthcare during the second quarter worth approximately $37,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.